Physician profile
Amy C Wall
NPI 1023324282
$5,039.90
in general payments reported to CMS, 2019-2025
32 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $598 · 2022: $1,561 · 2023: $1,047 · 2024: $747 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,801 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,801.24 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.53 | 2021-2025 | |
| Astellas Pharma US INC | $518.49 | 2022-2025 | Veozah |
| Sumitomo Pharma America, INC. | $442.26 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $346.60 | 2021-2025 | |
| Biogen, INC. | $329.67 | 2024-2025 | Zurzuvae |
| Ethicon US, LLC | $308.07 | 2021-2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| Amgen INC. | $284.82 | 2021-2024 | Prolia, Evenity |
| Daiichi Sankyo INC. | $255.26 | 2021-2023 | Injectafer |
| Glaxosmithkline, LLC. | $177.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.06 | 2021-2025 | |
| Exeltis, USA INC. | $137.07 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $136.96 | 2024-2025 | Coolseal Generator, Novasure, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Urovant Sciences INC | $133.79 | 2021-2022 | |
| Pfizer INC. | $129.98 | 2021-2023 | |
| Novo Nordisk INC | $127.85 | 2021-2025 | Wegovy |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $116.95 | 2022-2023 | |
| Agile Therapeutics, INC. | $110.88 | 2021-2022 | |
| Myovant Sciences INC. | $99.60 | 2022 | |
| Boston Scientific Corporation | $74.79 | 2021-2024 | Advantage System |
| Evofem Biosciences, INC. | $58.08 | 2021-2022 | |
| Organon LLC | $57.33 | 2021-2024 | Nexplanon |
| Therapeuticsmd, INC. | $54.72 | 2021-2022 | |
| Avion Pharmaceuticals | $53.58 | 2022-2023 | Balcoltra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.46 | 2021-2025 | Xifaxan |
| Shield Therapeutics INC | $41.08 | 2023 | Accrufer |
| Laborie Medical Technologies Corp. | $22.47 | 2023 | |
| Gynesonics, INC. | $21.05 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Biohaven Pharmaceuticals, INC. | $17.45 | 2021 | |
| Merck Sharp & Dohme LLC | $16.32 | 2023 | Gardasil 9 |
| Exact Sciences Corporation | $14.12 | 2025 | Cologuard Collection Kit |
| Axonics, INC. | $13.41 | 2022 | |
| Lilly USA, LLC | $13.16 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.